NAC (N-ACETYL L-CYSTEINE) 300 MG
Food supplement declared in France, declaration No 2024-5-387, decision dated 10 May 2024
NAC (N-ACETYL L-CYSTEINE) 300 MG (HSN) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Selenium, Vitamin B2 (riboflavin), Vitamin E, Acétylcystéine, L-leucine. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- HSN
- Food business operator placing the product on the market
- HARRISON SPORT NUTRITION, S.L.
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1 capsule
- Objectives stated by the manufacturer (these are not authorised claims)
- Antioxidant, Detox / Drainage, Sport
Declaration 175641, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Acétylcystéine | not declared |
| L-leucine | not declared |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| L-selenomethionine | Selenium | 255 µg | 50 µg |
| riboflavin | Vitamin B2 (riboflavin) | no limit (insufficient data) | dose annulled by the French Council of State in 2011 |
| D-alpha-tocopheryl acid succinate | Vitamin E | 300 mg | 30 mg |
Additives
E464, E341
Other ingredients
farine de riz
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
De manière générale, il est recommandé d’inviter les femmes enceintes et allaitantes à prendre l’attache d’un professionnel de santé avant toute complémentation.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Acétylcystéine
Read the warning, when it applies and the studies cited
N-ACETYL-L-CYSTEINE
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney stones (Fauci et al. 1998; Mårtensson et al. 1990).
Sources cited by Health Canada (2)
- Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DI, Hauser SL and Longo DL, editors. Harrison's Principles of Internal Medicine, 14th edition. Toronto (ON): McGraw-Hill Health Professions Division; 1998.
- Mårtensson J, Denneberg T, Lindell Å, Textorius O. Sulfur amino acid metabolism in cystinuria : A biochemical and clinical study of patients. Kidney International 1990;37:143-149. PubMed
Contraindications
Do not use if you are taking antibiotics or nitroglycerin (Repchinsky 2008; Cederlund and Märdh 1993; Parry and Neu 1977; Ardissino et al. 1997).
Sources cited by Health Canada (4)
- Ardissino D, Merlini PA, Savonitto S, Demicheli G, Zanini P, Bertocchi F, Falcone C, Ghio S, Marinoni G, Montemartini C, Mussini A. Effect of transdermal nitroglycerin or N- acetylcysteine, or both, in the long-term treatment of unstable angina pectoris. Journal of the American College of Cardiology 1997;29(5):941-947. PubMed Randomised trial
- Cederlund H, Märdh PA. Antibacterial activities of non-antibiotic drugs. Journal of Antimicrobial Chemotherapy 1993;32:355-365. PubMed Review article
- Parry MF, Neu HC. Effect of N-acetylcysteine on antibiotic activity and bacterial growth in vitro. Journal of Clinical Microbiology 1977;5(1);58-61.
- Repchinsky C, editor. Compendium of Pharmaceuticals and Specialties. The Canadian Drug Reference for Health Professionals. Ottawa (ON): Canadian Pharmacists Association; 2008.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : HSN
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “NAC (N-ACETYL L-CYSTEINE) 300 MG (HSN): composition and regulation”, https://compoatlas.com/en/supplements/products/175641-nac-n-acetyl-l-cysteine-300-mg, updated 15 November 2026.